Jackob Moskovitz

Jackob Moskovitz

Apr 11, 2019

Group 6 Copy 225
-1
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    Will vitamin D improve the health of patients with heart failure?

    We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function and...

    Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

    If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

    Campaign Ended

    A medicine project funded by 45 people